Early steroid withdrawal protocol using basiliximab in kidney transplantation

Transplant Proc. 2004 Mar;36(2 Suppl):478S-482S. doi: 10.1016/j.transproceed.2004.01.063.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Basiliximab
  • Cadaver
  • Cytomegalovirus Infections / epidemiology
  • Cytotoxicity, Immunologic / drug effects
  • Cytotoxicity, Immunologic / immunology
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / epidemiology
  • Graft Rejection / immunology
  • Histocompatibility Testing
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation / immunology*
  • Living Donors
  • Male
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / therapeutic use
  • Mycophenolic Acid / analogs & derivatives*
  • Postoperative Complications / epidemiology
  • Recombinant Fusion Proteins / therapeutic use*
  • Tissue Donors

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • Basiliximab
  • Mycophenolic Acid
  • Methylprednisolone